Bone Marrow TransplantationTransplantation, HomologousPeripheral Blood Stem Cell TransplantationGraft vs Host DiseaseHematopoietic Stem Cell TransplantationBone MarrowTransplantation ConditioningHematologic NeoplasmsBone Marrow CellsTransplantation ChimeraGraft SurvivalTissue DonorsWhole-Body IrradiationLeukemiaHematopoietic Stem Cell MobilizationBusulfanTransplantation, AutologousGranulocyte Colony-Stimulating FactorHistocompatibilityHistocompatibility TestingLeukapheresisRecurrenceTreatment OutcomeBone and BonesGraft vs Leukemia EffectImmunosuppressive AgentsAnemia, AplasticAntigens, CD34VidarabineT-LymphocytesPrecursor Cell Lymphoblastic Leukemia-LymphomaLiver TransplantationHLA AntigensMyeloablative AgonistsHematopoietic Stem CellsBone Marrow PurgingTransplantation ImmunologyTransplantation, IsogeneicSurvival AnalysisCyclophosphamideRetrospective StudiesDisease-Free SurvivalMice, Inbred C57BLBone Marrow DiseasesHematopoiesisLeukemia, Myeloid, AcuteCombined Modality TherapyKidney TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTime FactorsRadiation ChimeraLymphocyte TransfusionRemission InductionCyclosporineGraft RejectionStem Cell TransplantationChronic DiseaseHepatic Veno-Occlusive DiseaseLymphocyte DepletionImmunosuppressionGraft vs Host ReactionBone Marrow ExaminationAcute DiseaseLeukemia, MyeloidLeukocyte TransfusionLymphoma, Non-HodgkinBone RemodelingFlow CytometryMyelodysplastic SyndromesBone Marrow NeoplasmsGraft vs Tumor EffectHeart TransplantationChimeraLeukocytes, MononuclearSevere Combined ImmunodeficiencyColony-Forming Units AssayCells, CulturedHematologic DiseasesLeukocyte CountLymphocytesSpleenCytomegalovirus InfectionsCell DifferentiationAntineoplastic Combined Chemotherapy ProtocolsMice, Inbred BALB CBlood CellsActuarial AnalysisLymphocyte ActivationFollow-Up StudiesImmunophenotypingLung TransplantationSurvival RateNuclear FamilyBone DensityCytarabineMultiple MyelomaPancytopeniaCarmustineOrgan TransplantationLymphoma